MBM-01

Tempol · Matrix Biomed, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MBM-01, covering 2021-05-17 to 2021-05-17. Get the full timeline:

Most recent: Clinical Trial Update: MBM-01 (Tempol) for the Treatment of Ataxia Telangiectasia [Phase 2]